Renal C3 complement component: Feed forward to diabetic kidney disease

American Journal of Nephrology

Volumn 41, Issue 1, 2015, Pages 48-56

  Kelly, Katherine J ^a   Liu, Yunlong ^a   Zhang, Jizhong ^a   Dominguez, Jesus H ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Complement; Diabetic nephropathies; Ischemia; Kidney failure, chronic

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1QA; COMPLEMENT COMPONENT C1QB; COMPLEMENT COMPONENT C1QC; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9; COMPLEMENT MEMBRANE ATTACK COMPLEX; DECAY ACCELERATING FACTOR; MESSENGER RNA; UNCLASSIFIED DRUG; ANAPHYLATOXIN RECEPTOR C3A, RAT; COMPLEMENT; COMPLEMENT COMPONENT C5A RECEPTOR; G PROTEIN COUPLED RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; GENE; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA SEQUENCE; ANIMAL; CELL CULTURE; CELL HYPOXIA; COMPLICATION; CYTOLOGY; DISEASE MODEL; GENETICS; ISCHEMIA; KIDNEY; KIDNEY TUBULE; METABOLISM; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; ANTIGENS, CD55; ANTIGENS, CD59; CELL HYPOXIA; CELLS, CULTURED; COMPLEMENT C1Q; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT C5; COMPLEMENT C6; COMPLEMENT C8; COMPLEMENT C9; COMPLEMENT SYSTEM PROTEINS; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; ISCHEMIA; KIDNEY; KIDNEY TUBULES; MALE; OBESITY; RATS; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER;

EID: 84923081915     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000371426     Document Type: Article

References (59)

1. US Renal Data System: USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013.
2. Kelly KJ, Dominguez JH: Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure. Am J Nephrol 2010; 32: 469-475.
3. Dominguez J, Wu P, Packer CS, Temm C, Kelly KJ: Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy. Am J Physiol Renal Physiol 2007; 293:F670-F679.
4. Temm C, Dominguez JH: Microcirculation: nexus of comorbidities in diabetes. Am J Physiol Renal Physiol 2007; 293:F486-F493.
5. Breyer MD, Bottinger E, Brosius FC, Coffman TM, Fogo A, Harris RC, Heilig CW, Sharma K: Diabetic nephropathy: of mice and men. Adv Chronic Kidney Dis 2005; 12: 128-145.
6. Kelly KJ, Burford JL, Dominguez JH: Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy. Am J Physiol Renal Physiol 2009; 297:F923-F931.
7. Kelly KJ, Liu Y, Zhang J, Goswami C, Lin H, Dominguez JH: Comprehensive genomic profiling in diabetic nephropathy reveals the predominance of proinflammatory pathways. Physiol Genomics 2013; 45: 710-719.
8. Ricklin D, Hajishengallis G, Yang K, Lambris JD: Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010; 11: 785-797.
9. Muller-Eberhard HJ: Molecular organization and function of the complement system. Annu Rev Biochem 1988; 57: 321-347.
10. Ainsworth SK, Hirsch HZ, Brackett NC Jr, Brissie RM, Williams AV Jr, Hennigar GR: Diabetic glomerulonephropathy: histopathologic, immunofluorescent, and ultrastructural studies of cases. Hum Pathol 1982; 13: 470-478.
11. Fujita T, Ohi H, Komatsu K, Endo M, Ohsawa I, Kanmatsuse K: Complement activation accelerates glomerular injury in diabetic rats. Nephron 1999; 81: 208-214.
12. Kelly KJ, Zhang J, Han L, Wang M, Zhang S, Dominguez JH: Intravenous renal cell transplantation with SAA1-positive cells prevents progression of chronic renal failure in rats with ischemic-diabetic nephropathy. Am J Physiol Renal Physiol 2013; 305:F1804-F1812.
13. Homer N, Merriman B, Nelson SF: BFAST: an alignment tool for large scale genome resequencing. PLoS One 2009; 4:e7767.
14. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B: Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008; 5: 621-628.
15. Cohen CD, Lindenmeyer MT, Eichinger F, Hahn A, Seifert M, Moll AG, Schmid H, Kiss E, Grone E, Grone HJ, Kretzler M, Werner T, Nelson PJ: Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis. PLoS One 2008; 3:e2937.
16. Tang S, Zhou W, Sheerin NS, Vaughan RW, Sacks SH: Contribution of renal secreted complement C3 to the circulating pool in humans. J Immunol 1999; 162: 4336-4341.
17. Sheerin NS, Risley P, Abe K, Tang Z, Wong W, Lin T, Sacks SH: Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J 2008; 22: 1065-1072.
18. Sacks S, Zhou W: New boundaries for complement in renal disease. J Am Soc Nephrol 2008; 19: 1865-1869.
19. Yamada K, Miwa T, Liu J, Nangaku M, Song WC: Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol 2004; 172: 3869-3875.
20. Sacks SH, Zhou W, Pani A, Campbell RD, Martin J: Complement C3 gene expression and regulation in human glomerular epithelial cells. Immunology 1993; 79: 348-354.
21. Tang S, Sheerin NS, Zhou W, Brown Z, Sacks SH: Apical proteins stimulate complement synthesis by cultured human proximal tubular epithelial cells. J Am Soc Nephrol 1999; 10: 69-76.
22. Baruah P, Dumitriu IE, Peri G, Russo V, Mantovani A, Manfredi AA, Rovere-Querini P: The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. J Leukoc Biol 2006; 80: 87-95.
23. Liu S, Wu J, Zhang T, Qian B, Wu P, Li L, Yu Y, Cao X: Complement C1q chemoattracts human dendritic cells and enhances migration of mature dendritic cells to CCL19 via activation of AKT and MAPK pathways. Mol Immunol 2008; 46: 242-249.
24. Kirkitadze MD, Barlow PN: Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol Rev 2001; 180: 146-161.
25. Nilsson SC, Sim RB, Lea SM, Fremeaux-Bacchi V, Blom AM: Complement factor I in health and disease. Mol Immunol 2011; 48: 1611-1620.
26. Makou E, Herbert AP, Barlow PN: Functional anatomy of complement factor H. Biochemistry 2013; 52: 3949-3962.
27. Esterbauer H, Krempler F, Oberkofler H, Patsch W: The complement system: a pathway linking host defence and adipocyte biology. Eur J Clin Invest 1999; 29: 653-656.
28. Tegla CA, Cudrici C, Patel S, Trippe R 3rd, Rus V, Niculescu F, Rus H: Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res 2011; 51: 45-60.
29. Chen L, Flies DB: Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 2013; 13: 227-242.
30. Cao Q, McIsaac SM, Stadnyk AW: Human colonic epithelial cells detect and respond to C5a via apically expressed C5aR through the ERK pathway. Am J Physiol Cell Physiol 2012; 302:C1731-C1740.
31. Li K, Fazekasova H, Wang N, Peng Q, Sacks SH, Lombardi G, Zhou W: Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a. Immunobiology 2012; 217: 65-73.
32. Vibhuti A, Gupta K, Subramanian H, Guo Q, Ali H: Distinct and shared roles of beta-arrestin-1 and beta-arrestin-2 on the regulation of C3a receptor signaling in human mast cells. PLoS One 2011; 6:e19585.
33. Kawamoto S, Yalcindag A, Laouini D, Brodeur S, Bryce P, Lu B, Humbles AA, Oettgen H, Gerard C, Geha RS: The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen. J Clin Invest 2004; 114: 399-407.
34. Reis ES, Barbuto JA, Kohl J, Isaac L: Impaired dendritic cell differentiation and maturation in the absence of C3. Mol Immunol 2008; 45: 1952-1962.
35. Peng Q, Li K, Wang N, Li Q, Asgari E, Lu B, Woodruff TM, Sacks SH, Zhou W: Dendritic cell function in allostimulation is modulated by C5aR signaling. J Immunol 2009; 183: 6058-6068.
36. Ducruet AF, Hassid BG, Mack WJ, Sosunov SA, Otten ML, Fusco DJ, Hickman ZL, Kim GH, Komotar RJ, Mocco J, Connolly ES: C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent. J Cereb Blood Flow Metab 2008; 28: 1048-1058.
37. Peng Q, Li K, Patel H, Sacks SH, Zhou W: Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J Immunol 2006; 176: 3330-3341.
38. Baruah P, Dumitriu IE, Malik TH, Cook HT, Dyson J, Scott D, Simpson E, Botto M: C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells. Blood 2009; 113: 3485-3493.
39. Lalli PN, Strainic MG, Lin F, Medof ME, Heeger PS: Decay accelerating factor can control T cell differentiation into IFN-gammaproducing effector cells via regulating local C5a-induced IL-12 production. J Immunol 2007; 179: 5793-5802.
40. Bora PS, Sohn JH, Cruz JM, Jha P, Nishihori H, Wang Y, Kaliappan S, Kaplan HJ, Bora NS: Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol 2005; 174: 491-497.
41. Klos A, Tenner AJ, Johswich KO, Ager RR, Reis ES, Kohl J: The role of the anaphylatoxins in health and disease. Mol Immunol 2009; 46: 2753-2766.
42. Foreman KE, Vaporciyan AA, Bonish BK, Jones ML, Johnson KJ, Glovsky MM, Eddy SM, Ward PA: C5a-induced expression of Pselectin in endothelial cells. J Clin Invest 1994; 94: 1147-1155.
43. Del Conde I, Cruz MA, Zhang H, Lopez JA, Afshar-Kharghan V: Platelet activation leads to activation and propagation of the complement system. J Exp Med 2005; 201: 871-879.
44. Noris M, Mescia F, Remuzzi G: STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 2012; 8: 622-633.
45. Kilgore KS, Ward PA, Warren JS: Neutrophil adhesion to human endothelial cells is induced by the membrane attack complex: the roles of P-selectin and platelet activating factor. Inflammation 1998; 22: 583-598.
46. Floreani AA, Wyatt TA, Stoner J, Sanderson SD, Thompson EG, Allen-Gipson D, Heires AJ: Smoke and C5a induce airway epithelial intercellular adhesion molecule-1 and cell adhesion. Am J Respir Cell Mol Biol 2003; 29: 472-482.
47. Venkatesha RT, Berla Thangam E, Zaidi AK, Ali H: Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol Immunol 2005; 42: 581-587.
48. Brasier AR: The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 2010; 86: 211-218.
49. Arora S, Bhardwaj A, Singh S, Srivastava SK, McClellan S, Nirodi CS, Piazza GA, Grizzle WE, Owen LB, Singh AP: An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor kappaB-and hypoxia-inducible factor 1alpha-mediated upregulation of CXCR4. J Biol Chem 2013; 288: 21197-21207.
50. Lisi S, Sisto M, Lofrumento DD, D'Amore M: Sjogren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-kappaB. Lab Invest 2012; 92: 615-624.
51. Cowley MJ, Weinberg A, Zammit NW, Walters SN, Hawthorne WJ, Loudovaris T, Thomas H, Kay T, Gunton JE, Alexander SI, Kaplan W, Chapman J, O'Connell PJ, Grey ST: Human islets express a marked proinflammatory molecular signature prior to transplantation. Cell Transplant 2012; 21: 2063-2078.
52. Burke SJ, Goff MR, Lu D, Proud D, Karlstad MD, Collier JJ: Synergistic expression of the CXCL10 gene in response to IL-1beta and IFN-gamma involves NF-kappaB, phosphorylation of STAT1 at Tyr701, and acetylation of histones H3 and H4. J Immunol 2013; 191: 323-336.
53. Pietila TE, Veckman V, Lehtonen A, Lin R, Hiscott J, Julkunen I: Multiple NF-kappaB and IFN regulatory factor family transcription factors regulate CCL19 gene expression in human monocyte-derived dendritic cells. J Immunol 2007; 178: 253-261.
54. Burke SJ, Lu D, Sparer TE, Masi T, Goff MR, Karlstad MD, Collier JJ: NF-kappaB and STAT1 control CXCL1 and CXCL2 gene transcription. Am J Physiol Endocrinol Metab 2014; 306:E131-E149.
55. Parthasarathy A, Gopi V, Umadevi S, Simna A, Sheik MJ, Divya H, Vellaichamy E: Suppression of atrial natriuretic peptide/natriuretic peptide receptor-A-mediated signaling upregulates angiotensin-II-induced collagen synthesis in adult cardiac fibroblasts. Mol Cell Biochem 2013; 378: 217-228.
56. Boor P, Konieczny A, Villa L, Schult AL, Bucher E, Rong S, Kunter U, van Roeyen CR, Polakowski T, Hawlisch H, Hillebrandt S, Lammert F, Eitner F, Floege J, Ostendorf T: Complement C5 mediates experimental tubulointerstitial fibrosis. J Am Soc Nephrol 2007; 18: 1508-1515.
57. Huang G, Zhang Y, Kim B, Ge G, Annis DS, Mosher DF, Greenspan DS: Fibronectin binds and enhances the activity of bone morphogenetic protein 1. J Biol Chem 2009; 284: 25879-25888.
58. Stevens MG, Van Poucke M, Peelman LJ, Rainard P, De Spiegeleer B, Rogiers C, Van de Walle GR, Duchateau L, Burvenich C: Anaphylatoxin C5a-induced toll-like receptor signaling in bovine neutrophils. J Dairy Sci 2011; 94: 152-164.
59. Brown GT, Narayanan P, Li W, Silverstein RL, McIntyre TM: Lipopolysaccharide stimulates platelets through an IL-1beta autocrine loop. J Immunol 2013; 191: 5196-5203.